
Vaccine Vial Monitor Market by Type (Multi-Dose, Single Dose), Application (Preventive Vaccine, Therapeutic Vaccine) - Global Forecast 2024-2030
Description
Vaccine Vial Monitor Market by Type (Multi-Dose, Single Dose), Application (Preventive Vaccine, Therapeutic Vaccine) - Global Forecast 2024-2030
The Vaccine Vial Monitor Market size was estimated at USD 224.25 million in 2023 and expected to reach USD 275.38 million in 2024, at a CAGR 22.89% to reach USD 949.27 million by 2030.
Global Vaccine Vial Monitor Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Vaccine Vial Monitor Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vaccine Vial Monitor Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Vaccine Vial Monitor Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Vaccine Vial Monitor Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Multi-Dose
Single Dose
Application
Preventive Vaccine
Therapeutic Vaccine
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Vaccine Vial Monitor Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vaccine Vial Monitor Market?
3. What are the technology trends and regulatory frameworks in the Vaccine Vial Monitor Market?
4. What is the market share of the leading vendors in the Vaccine Vial Monitor Market?
5. Which modes and strategic moves are suitable for entering the Vaccine Vial Monitor Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
190 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Vaccine Vial Monitor Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Demand for administration and importance to the safe use of the vaccines
- 5.1.1.2. Need for adequate monitoring of vaccine vials
- 5.1.1.3. High prevalence of infectious diseases and a growing number of initiatives to promote immunization
- 5.1.2. Restraints
- 5.1.2.1. Issues associated with applications, and logistics
- 5.1.3. Opportunities
- 5.1.3.1. Relationship between vaccine vial monitors and cold chain infrastructure
- 5.1.3.2. Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
- 5.1.4. Challenges
- 5.1.4.1. Stingent regulatory consideration for VVM
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Vaccine Vial Monitor Market, by Type
- 6.1. Introduction
- 6.2. Multi-Dose
- 6.3. Single Dose
- 7. Vaccine Vial Monitor Market, by Application
- 7.1. Introduction
- 7.2. Preventive Vaccine
- 7.3. Therapeutic Vaccine
- 8. Americas Vaccine Vial Monitor Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Vaccine Vial Monitor Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Vaccine Vial Monitor Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Cardinal Health, Inc.
- 12.1.2. Catalent, Inc.
- 12.1.3. Corning Incorporated
- 12.1.4. DWK Life Sciences GmbH
- 12.1.5. Elitech Technology, Inc.
- 12.1.6. ELPRO-BUCHS AG
- 12.1.7. EVIGENCE SENSORS Inc.
- 12.1.8. Gerresheimer AG
- 12.1.9. Lisaline Lifescience Technologies Pvt Ltd.
- 12.1.10. Nipro Corporation
- 12.1.11. Pacific Vial Manufacturing Inc.
- 12.1.12. Schott AG
- 12.1.13. Stevanato Group
- 12.1.14. Temptime Corporation by Zebra Technologies Corporation
- 12.1.15. Thermo Fisher Scientific Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. VACCINE VIAL MONITOR MARKET RESEARCH PROCESS
- FIGURE 2. VACCINE VIAL MONITOR MARKET SIZE, 2023 VS 2030
- FIGURE 3. VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. VACCINE VIAL MONITOR MARKET DYNAMICS
- FIGURE 7. VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.